Dr. Thomas Howard Cartwright, MD

Dr. Cartwright practices at Atrium Health Navicent The Medical Center in Macon, Georgia.

Dr. Cartwright's NPI, 1760442313, was assigned on March 27, 2006. Dr. Cartwright graduated from Feinberg School of Medicine in 1976. Dr. Cartwright holds Florida license ME38124.

Dr. Cartwright's primary practice is Atrium Health Navicent the Medical Center, at 777 Hemlock St, Macon, GA 31201 in Bibb County. The practice phone is (478) 633-1000.

Dr. Cartwright's primary practice is Atrium Health Navicent The Medical Center in Macon, Georgia. Dr. Cartwright is also affiliated with St. Peter's Health Regional Medical Center. The medical group on file is Atrium Health Navicent Medical Group. Dmand AI also links Dr. Cartwright to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cartwright practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Cartwright's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Cartwright is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Cartwright's licenses on file in 5 states: Florida, Georgia, Tennessee, Maryland and Illinois.

Dmand AI lists chronic anemia, colorectal cancer and lung cancer among the conditions Dr. Cartwright treats.

CMS data shows 64 Medicare services from Dr. Cartwright across 2 procedure codes in 2024, for 55 Medicare patients. Medicare paid $2,771 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 55 Medicare patients who saw Dr. Cartwright in 2024. The largest group is 75 to 84, with 24 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cartwright's median patient age at 74, with 57% women.

In 2024, Dr. Cartwright wrote 32 Medicare Part D claims for 20 patients. 97% of them were for generic drugs. They cover 19 drugs, with $481,634 in total drug cost.

Dr. Cartwright accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 38 papers to Dr. Cartwright, published from 2009 to 2020. 2012 was the busiest year, with 5. The most frequent topics are Colorectal Neoplasms, Fluorouracil and Antineoplastic Combined Chemotherapy Protocols. Dr. Cartwright has published most often in Clin Colorectal Cancer. Dr. Cartwright's most frequent co-authors are Mokenge P. Malafa, MD, Guillermo Abesada-Terk, MD and Carlos A. Alemany, MD.

Dmand AI links Dr. Cartwright to 6 clinical trials, 2 of them phase 2 studies. Conditions studied include Breast Neoplasms, Neoplasm Metastasis and Noonan Syndrome 5. Open Payments lists research payments to Dr. Cartwright that name 1 trial.

CMS Open Payments shows 872 general payments to Dr. Cartwright from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Amgen Inc. paid the most, $193,247. It also lists 11 research payments totaling $243,341 from 2016 to 2020, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Cartwright, most recently CMS Stage 1 2012 in 2012.

Dr. Cartwright graduated from Feinberg School of Medicine in 1976. Dr. Cartwright is a member of ASCO.

Dr. Cartwright is in network with 17 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.